Bob Thoolen
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Carcinogens and Genotoxicity Assessment 3
-
- Animal testing and alternatives 2
- Co-authors
- David E. Malarkey (2 shared papers)Robert R. Maronpot (3 shared papers)Colin G. Rousseaux (1 shared paper)R. L. Gregson (1 shared paper)Dai Nakae (1 shared paper)Amy E. Brix (1 shared paper)Wolfgang Kaufmann (1 shared paper)Takanori Harada (1 shared paper)
- Journals
- Toxicologic Pathology (4 papers)Human & Experimental Toxicology (1 paper)Journal of Toxicologic Pathology (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Bob Thoolen
4 papers receiving 499 citations
Peers
Comparison fields: 5 of 100
- Pharmacology 75
- Cancer Research 92
- Hepatology 47
- Small Animals 40
- Health, Toxicology and Mutagenesis 60
Countries citing papers authored by Bob Thoolen
This map shows the geographic impact of Bob Thoolen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Thoolen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Thoolen more than expected).
Fields of papers citing papers by Bob Thoolen
This network shows the impact of papers produced by Bob Thoolen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Thoolen. The network helps show where Bob Thoolen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bob Thoolen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 471 | |
| 2 | 2012 | 35 | |
| 3 | 2004 | 7 | |
| 4 | 2002 | 4 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 |
About Bob Thoolen
Bob Thoolen is a scholar working on Cancer Research, Small Animals, Oncology, Epidemiology and Immunology, having authored 6 papers that have together received 517 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (3 papers), Immunotoxicology and immune responses (2 papers), Animal testing and alternatives (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), DNA Repair Mechanisms (1 paper), Lung Cancer Research Studies (1 paper), Neuroblastoma Research and Treatments (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Pharmacology (75 citations), Cancer Research (92 citations), Hepatology (47 citations), Small Animals (40 citations) and Health, Toxicology and Mutagenesis (60 citations). Bob Thoolen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include David E. Malarkey, Robert R. Maronpot, Colin G. Rousseaux, R. L. Gregson, Dai Nakae, Amy E. Brix, Wolfgang Kaufmann, Takanori Harada, Ulrich Deschl and Karin Küttler. Their work appears in journals such as Toxicologic Pathology, Human & Experimental Toxicology and Journal of Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.